Cargando…

Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report

We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokarski, Rebecca M., Knecht, Vincent, Bezjak, Johanna D., Ray, Evan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024036/
https://www.ncbi.nlm.nih.gov/pubmed/36941847
http://dx.doi.org/10.1016/j.xkme.2023.100611
_version_ 1784909021129474048
author Tokarski, Rebecca M.
Knecht, Vincent
Bezjak, Johanna D.
Ray, Evan C.
author_facet Tokarski, Rebecca M.
Knecht, Vincent
Bezjak, Johanna D.
Ray, Evan C.
author_sort Tokarski, Rebecca M.
collection PubMed
description We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology clinic for evaluation and management of severe, chronic hypomagnesemia because of renal magnesium wasting in combination with frequent diarrhea. Clinical manifestations associated with hypomagnesemia included muscle weakness, cognitive impairment, and frequent seizures. Her hypomagnesemia had persisted for more than 20 years despite maximal oral magnesium supplementation and frequent intravenous magnesium infusions. To provide slower delivery of parenteral magnesium, she was prescribed 2 g/d of magnesium sulfate, delivered subcutaneously. This was well tolerated, rapidly normalized her serum magnesium levels, and improved her symptoms. We briefly discuss modalities used for treatment of hypomagnesemia, including shortcomings of intravenous therapy and limited literature discussing efficacy and tolerability of subcutaneous infusions. This case report demonstrates the efficacy and safety of subcutaneous magnesium infusions in a patient with refractory hypomagnesemia and suggests that subcutaneous infusion may be safe and effective for treatment of refractory hypomagnesemia in other patients with urinary magnesium wasting.
format Online
Article
Text
id pubmed-10024036
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-100240362023-03-19 Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report Tokarski, Rebecca M. Knecht, Vincent Bezjak, Johanna D. Ray, Evan C. Kidney Med Case Report We describe a patient with renal magnesium wasting and prolonged, symptomatic hypomagnesemia that was refractory to oral therapies and intermittent intravenous infusion who achieved near-normal serum magnesium levels with subcutaneous magnesium infusions. A woman in her 40s was seen in nephrology clinic for evaluation and management of severe, chronic hypomagnesemia because of renal magnesium wasting in combination with frequent diarrhea. Clinical manifestations associated with hypomagnesemia included muscle weakness, cognitive impairment, and frequent seizures. Her hypomagnesemia had persisted for more than 20 years despite maximal oral magnesium supplementation and frequent intravenous magnesium infusions. To provide slower delivery of parenteral magnesium, she was prescribed 2 g/d of magnesium sulfate, delivered subcutaneously. This was well tolerated, rapidly normalized her serum magnesium levels, and improved her symptoms. We briefly discuss modalities used for treatment of hypomagnesemia, including shortcomings of intravenous therapy and limited literature discussing efficacy and tolerability of subcutaneous infusions. This case report demonstrates the efficacy and safety of subcutaneous magnesium infusions in a patient with refractory hypomagnesemia and suggests that subcutaneous infusion may be safe and effective for treatment of refractory hypomagnesemia in other patients with urinary magnesium wasting. Elsevier 2023-02-07 /pmc/articles/PMC10024036/ /pubmed/36941847 http://dx.doi.org/10.1016/j.xkme.2023.100611 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Tokarski, Rebecca M.
Knecht, Vincent
Bezjak, Johanna D.
Ray, Evan C.
Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
title Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
title_full Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
title_fullStr Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
title_full_unstemmed Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
title_short Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
title_sort home subcutaneous magnesium infusion in refractory hypomagnesemia: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024036/
https://www.ncbi.nlm.nih.gov/pubmed/36941847
http://dx.doi.org/10.1016/j.xkme.2023.100611
work_keys_str_mv AT tokarskirebeccam homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport
AT knechtvincent homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport
AT bezjakjohannad homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport
AT rayevanc homesubcutaneousmagnesiuminfusioninrefractoryhypomagnesemiaacasereport